SIGA - NASDAQ

SIGA Technologies, Inc.

SIGA·NASDAQ

$4.29

-0.69%

HealthcareDrug Manufacturers - Specialty & Generic

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$307.70M

EPS0.3300

P/E Ratio13.00

Earnings Date07/30/2026

219.47M

Assets

-10%

3Y+13.0%

5Y+46.0%

10Y+36.0%

20.65M

Total Liabilities

-28%

3Y-17.0%

5Y+3.0%

10Y-95.0%

198.82M

Total Equity

-8%

3Y+17.0%

5Y+53.0%

10Y-169.0%

SIGA Technologies, Inc. Funding & Solvency Profile

SIGA · NASDAQ

Current Assets

Cash & Cash Equivalents154.97M

Net Receivables3.26M

Inventory49.05M

Other Current Assets5.57M

Total Current Assets213 M

Non-Current Assets

Property, Plant & Equipment1.09M

Goodwill & Intangible Assets898.33K

Long-Term Investments0.00

Other Non-Current Assets192.89K

Total Non-Current Assets1 M

Total Assets

219.47M

Financial Health Analysis

Current Ratio

11.83x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.10x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

195 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

97% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

SIGA Technologies, Inc. Balance Sheet

SIGA • NASDAQ

SIGA Technologies, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	155M	155.4M	150.1M	98.8M	103.1M	117.9M	65.2M	100.7M	19.9M	28.7M	112.7M	99.7M	91.3M	32M	49.3M	6.3M	14.5M	2.3M	6.8M	10.6M
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15M	5M	0.0	0.0	0.0
Cash & Short-Term Investments	155M	155.4M	150.1M	98.8M	103.1M	117.9M	65.2M	100.7M	19.9M	28.7M	112.7M	99.7M	91.3M	32M	49.3M	21.3M	19.5M	2.3M	6.8M	10.6M
Net Receivables	3.3M	21.2M	21.1M	45.4M	83.7M	3.3M	4.2M	2M	1.8M	3.2M	3.7M	491.6K	982K	970.3K	2.6M	3M	2.4M	2M	986.5K	617K
Accounts Receivables	3.3M	21.2M	21.1M	45.4M	83.7M	3.3M	4.2M	2M	1.8M	3.2M	3.7M	491.6K	982K	970.3K	2.6M	3M	2.4M	2M	986.5K	617K
Inventory	49.1M	49.6M	64.2M	39.3M	19.5M	20.3M	9.7M	2.9M	3M	26.2M	12.4M	19M	20.5M	17.6M	0.0	0.0	0.0	1.4M	0.0	0.0
Prepaids	0.0	0.0	0.0	0.0	2.5M	2.1M	5.2M	4.3M	2M	954.4K	624K	898.7K	750.8K	801.1K	356.9K	369K	1.6M	2M	130.1K	141K
Other Current Assets	5.6M	4.9M	3.5M	2.3M	0.0	0.0	95.7M	11.5M	10.7M	10.1M	0.0	4M	10.4M	33.5M	727.8K	0.0	0.0	0.0	0.0	0.0
Total Current Assets	212.9M	231M	239M	185.8M	208.8M	143.6M	180M	121.3M	37.4M	69.2M	129.5M	129.8M	123.9M	84.9M	53M	24.7M	23.5M	6.3M	7.9M	11.4M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	1.1M	1.3M	1.3M	1.8M	2.4M	2.1M	2.6M	171.3K	138.6K	299.5K	449.8K	831.9K	1.4M	987.9K	819K	1.2M	1.2M	1.4M	1.5M	1.3M
Goodwill	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	165.2K
Goodwill & Intangible Assets	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	898.3K	1.1M
Long-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.3M	96.6M	-213.4M	-212.7M	-5.6B	22.6M	6.6M	0.0	-175.2M	0.0	0.0	0.0	0.0
Tax Assets	4.4M	10.9M	11M	6.3M	2.4M	2.5M	14.2M	11.7M	2.4M	286.1M	265.6M	5.7B	42.9M	10.2M	35.1M	175.2M	0.0	0.0	0.0	0.0
Other Non-Current Assets	192.9K	240.7K	2.1M	252.5K	286.6K	676.9K	856.8K	1.1M	7.2M	18M	2M	2M	2.1M	2.2M	535.4K	280.6K	304.8K	283.9K	261.8K	246.2K
Total Non-Current Assets	6.6M	13.3M	15.4M	9.2M	6M	6.2M	18.5M	82.2M	107.3M	91.8M	56.3M	36.6M	69.9M	20.9M	37.4M	2.3M	2.4M	2.5M	2.6M	2.6M
Total Assets	219.5M	244.3M	254.4M	195M	214.7M	149.8M	198.6M	203.4M	144.7M	161M	185.7M	166.4M	193.8M	105.8M	90.4M	27M	25.9M	8.8M	10.6M	14M
LIABILITIES
CURRENT LIABILITIES
Total Payables	1.9M	9.4M	23.1M	4.7M	21.2M	2.2M	3.1M	1.7M	1.3M	2.5M	3.9M	3.4M	5.1M	10.2M	2.3M	2.9M	3.5M	1.8M	1.3M	1.4M
Accounts Payable	824.5K	1.3M	1.5M	3.4M	2M	1.3M	3.1M	1.7M	1.3M	2.5M	3.9M	3.4M	5.1M	10.2M	2.3M	2.9M	3.5M	1.8M	1.3M	1.4M
Other Payables	1.1M	8M	21.7M	1.3M	19.2M	919.6K	7.1K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	1.3M	2M	2.8M	2.1M	783.4K	1.1M	2.3M	4.6M	2.9M	2.6M	1.4M	17.5K	1M	250K	1.1M	1.2M	740.3K	1.2M	202K	201.8K
Short Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	80M	0.0	0.0	0.0	0.0	2M	2M	954.7K	0.0	0.0	0.0	0.0	0.0	107.5K
Capital Lease Obligations (Current)	595.2K	546.8K	564K	528.2K	466.8K	449.9K	419.7K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	408B	8M	21.7M	1.3M	19.2M	919.6K	7.1K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	10.2M	10.3M	20.8M	10.5M	3.8M	3.3M	2.3M	4.2M	1.3M	367.5B	255.3B	81.8M	162.2B	57.1B	41B	190.8K	1.6M	1.3M	0.0	0.0
Other Current Liabilities	4M	3.1M	6.8M	3.7M	4.2M	3.4M	3.6M	5M	1.4M	8.7M	2M	2.1M	4.1M	4.3M	3.6M	0.0	3.3M	0.0	594.5K	382.7K
Total Current Liabilities	18M	25.3M	54.1M	21.5M	30.5M	10.5M	91.7M	11.3M	6.8M	13.8M	7.3M	7.5M	12.2M	15.7M	6.9M	4.3M	9M	4.3M	2.1M	2M
NON-CURRENT LIABILITIES
Long Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.5M	71.1M	66.6M	0.0	0.0	2M	4M	0.0	0.0	0.0	0.0	0.0	22.8K
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-479.4K	377.6M	367.5M	255.3M	81.8K	162.2M	57.1M	41M	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	479.4K	11.5M	286.1K	265.6K	5.9M	0.0	0.0	0.0	175.2K	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	2.7M	3.2M	3.4M	3.4M	9.9M	9.6M	9M	13.6M	12.3M	-26.6M	207.3M	399.4M	447.6K	166.3K	770.5K	10.5M	6.4M	2.9M	3.2M	4.7M
Total Non-Current Liabilities	2.7M	3.2M	3.4M	3.4M	9.9M	9.6M	9M	89.2M	461M	434.6M	462.8M	405.4M	164.7M	61.2M	41.8M	10.7M	6.4M	2.9M	3.2M	4.7M
Capital Lease Obligations	595.2K	546.8K	564K	528.2K	466.8K	449.9K	419.7K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	20.6M	28.5M	57.5M	24.9M	40.4M	20M	100.8M	100.5M	467.8M	448.4M	470.2M	412.9M	176.8M	76.9M	48.7M	15M	15.4M	7.2M	5.4M	6.7M
SHAREHOLDERS' EQUITY
Common Stock	7.2K	7.1K	7.1K	7.3K	7.4K	7.7K	8.1K	8.1K	7.9K	7.9K	5.4K	5.4K	5.3K	5.2K	5.2K	4.9K	4.3K	3.5K	3.4K	3.2K
Additional Paid-In Capital	241.9M	238.6M	235.8M	234M	226.1M	225M	220.8M	218.7M	214.2M	213.7M	177M	175.5M	173.5M	152.3M	150.6M	134.5M	101.4M	72.2M	67.2M	63.6M
Retained Earnings	-43.1M	-22.8M	-38.9M	-63.8M	-51.8M	-95.2M	-123M	-115.8M	-537.4M	-501.1M	-461.4M	-422M	-156.5M	-123.4M	-108.9M	-122.5M	-90.9M	-70.6M	-62M	-56.4M
Accumulated Other Comprehensive Income/Loss	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-3.2M	-3.3M	-3.5M	-3.3M	-3.5M	-5.4M	-4.9M	-5.7M	4.1K	-4.5M	-4.1M	-3.7M	-2.9M
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5M	3.3M	3.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	198.8M	215.8M	196.9M	170.2M	174.3M	129.8M	97.8M	102.9M	-323.1M	-287.4M	-284.4M	-246.5M	17M	28.9M	41.7M	12.1M	10.5M	1.6M	5.2M	7.3M
Total Equity	198.8M	215.8M	196.9M	170.2M	174.3M	129.8M	97.8M	102.9M	-323.1M	-287.4M	-284.4M	-246.5M	17M	28.9M	41.7M	12.1M	10.5M	1.6M	5.2M	7.3M
SUMMARY
Total Liabilities & Equity	219.5M	244.3M	254.4M	195M	214.7M	149.8M	198.6M	203.4M	144.7M	161M	185.7M	166.4M	193.8M	105.8M	90.4M	27M	25.9M	8.8M	10.6M	14M
Total Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.3M	96.6M	-213.4M	-212.7M	-5.6B	22.6M	6.6M	0.0	-160.2M	5M	0.0	0.0	0.0
Total Debt	595.2K	546.8K	564K	528.2K	466.8K	449.9K	80.5M	75.5M	71.1M	66.6M	0.0	2M	4M	4.9M	0.0	0.0	0.0	0.0	0.0	130.3K
Net Debt	-154.4M	-154.9M	-149.6M	-98.3M	-102.7M	-117.4M	15.2M	-25.1M	51.2M	37.9M	-112.7M	-97.7M	-87.4M	-27.1M	-49.3M	-6.3M	-14.5M	-2.3M	-6.8M	-10.5M
Shares Outstanding	71,611,300	71,611,300	71,611,300	71,611,300	71,611,300	71,611,300	71,611,300	71,611,300	71,611,300	71,611,300	71,611,300	71,611,300	71,611,300	71,611,300	71,611,300	71,611,300	71,611,300	71,611,300	71,611,300	71,611,300

SEC Filings

SIGA - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-Q 10-Q 2026 Q1 Q1	May 07, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 07, 2026	May 07, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 28, 2026	June 09, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 26, 2026	March 26, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 10, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	March 10, 2026	March 10, 2026	2026	View Filing
10-Q 10-Q 2025 Q3 Q3	November 06, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 06, 2025	November 06, 2025	2025	View Filing
8-K 8-K 2025 N/A	August 05, 2025	August 05, 2025	2025	View Filing
10-Q 10-Q 2025 Q2 Q2	August 05, 2025	June 30, 2025	2025	View Filing

Showing 1 to 10 of 378 filings

Related Guides

Blog Categories

Continue your SIGA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.